Company page

Cel-sci Corporation

Cel-sci Corporation, trading under the ticker CVM, is a public company based in the United States with a market capitalization of approximately $15.1 million. The company is focused on developing innovative therapies for cancer and other diseases. Cel-sci is dedicated to advancing its research and clinical programs to improve patient outcomes.